4DMedical™ CT Suite
Turning medical images into life-changing insights
4DMedical™ CT Suite
Turning medical images into life-changing insights
Use advanced visualization and algorithm-based technology to turn standard medical imaging into personalized medicine by transforming the way clinical conditions are discovered, diagnosed, treated and managed.
ㅤ
Features
Lung Density Analysis (LDA™), Functional (LDAf)
LDAf is designed to support physician’s diagnosis, care planning and follow-up for patients with conditions where air-trapping may be present (e.g. COPD, BOS, Asthma). LDAf software runs automatically on paired inspiratory/expiratory chest CT series with no user input or intervention and performs a patented analysis to visualize and quantify areas with abnormal tissue density potentially indicative of air trapping, distinctly separate from those indicative of emphysema. LDAf performs this functional classification of lung parenchyma and results are directly routed to PACS for review.
Coronary Artery Calcification Analysis (CAC™)
CAC™ is a deep learning AI analysis trained to assess gated or ungated CT scans, and to be effective in analyzing either standard dose CT’s, or low dose chest CT scans as a component of lung cancer screening programs. CAC™ analysis identifies suspect coronary calcifications and provides an overall patient Agatston Score, Arterial age and risk stratification, and further provides the number of lesions, lesion volume, lesion mass, and Agatston score for each of the main coronary arteries.
Lung Density Analysis (LDA™), Inspiratory (LDAi)
Designed to support physician’s diagnosis, care planning and follow-up for patients, LDAi provides visualization and quantification of areas in the lungs with abnormal CT tissue density including areas with low-density (LAA) indicative of emphysema, and areas with high density (HAA) potentially indicative of ILA’s. LDAi software runs automatically on inspiration-only chest CT series with no user input or intervention and performs segmentation, thresholding, and classification of lung parenchyma. LDAi application results are directly routed to PACS for review.
Recommended products
- Philips is offering the XV LVAS™ from 4DMedical, a Software as a Service (SaaS) that uses fluoroscopic lung images from existing hospital equipment to quantify regional lung ventilation in a comprehensive but easy-to-interpret report that includes 4D video visualizations. Areas of high and low ventilation are highlighted and ventilation heterogeneity – a recognized indicator of lung health – is quantified. XV LVAS™ provides regional quantification of lung function, including Lung Volume, Ventilation Heterogeneity and Ventilation Defect Percentage with four-dimensional imaging – 3D + time. Includes easy-to-read visualization of regional lung ventilation and actionable insights into lung function to better characterize and quantify respiratory conditions and symptoms including lung health assessment for toxic exposure, VA-specific lung cancer screening, COPD, and Sarcoidosis/long COVID, with no need for contrast agents.
- The clinical presentation of unexplained dyspnea, or shortness of breath, can be complex. Imaging plays a crucial role in the diagnostic process, but anatomical findings can overlap, lag or precede clinical symptoms. CT lung ventilation analysis significantly enhances diagnostic reports, providing actionable information. Philips offers the 4DMedical™ CT LVAS™ as a Software-as-a-Service (SasS) to allow clinicians to better characterize lung conditions and detect associated regional lung changes. CT-LVAS™ provides regional quantification of lung function, including lung volumes, ventilation heterogeneity, and ventilation defect percentage with easy-to-read, color-coded visualization. Gives detailed, actionable insights into lung function to better characterize and quantify respiratory conditions and symptoms including lung health assessment for toxic exposure, VA-specific lung cancer screening, COPD, Sarcoidosis/long COVID, and more. Compatible with existing imaging equipment with no need for contrast agents.
Disclaimer
Philips is an authorized partner of 4DMedical™. LDA™, CAC™, and PHA™ are registered trademarks of 4DMedical™ or its affiliates.